Pneumonia vaccine study for healthy infants 2 months old
Part of Infections clinical trials.
This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby should be between 6 and 12 weeks old (42 to 89 days).
- Your baby must be generally healthy, with no serious medical conditions.
- Your baby must have been born at full term (37 weeks or later) weighing at least 5.5 pounds, or born between 28 and 36 weeks weighing at least 3.3 pounds and medically stable.
- Your baby cannot have already received a pneumococcal vaccine.
- Your baby cannot have a weakened immune system or be on medicines that suppress the immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
This study tests a new pneumococcal vaccine (PCV24) for babies ages 2 to 23 months. It aims to see if the vaccine is safe and helps protect against serious infections like pneumonia and meningitis.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
This study tests a pneumococcal vaccine (PCV13) in healthy 2-month-old babies to see if it is safe and helps protect against pneumococcal infections. Your baby would receive the vaccine and be monitored for any side effects.
This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.
This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.
Hear when a new Pneumococcal Immunization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.